75
Participants
Start Date
March 1, 2021
Primary Completion Date
April 14, 2023
Study Completion Date
April 14, 2023
Diroximel Fumarate
As described in the arm.
Jacobs School of Medicine and Biomedical Sciences, Buffalo
Geisinger Medical Center, Danville
MedStar Georgetown University Hospital, Washington D.C.
Riverside Neurology Specialists, Newport News
Cone Health, Greensboro
Hope Neurology, Knoxville
Norton Neuroscience Institute, Louisville
Glendale Neurological Associates, PC, Farmington
Memorial Healthcare, Owosso
St. Luke's Neurology, Kansas City
UTHealth Neurosciences Texas Medical Center II, Houston
Regina Berkovich MD Phd Inc, West Hollywood
Providence Brain and Spine Institute, Portland
Providence Medical Research Center, Spokane
Beth Israel Deaconess Medical Center, Boston
CentraState Healthcare System - Linda Cardinale MS Center, Freehold
MS Center at St Barnabas, Livingston
Multiple Sclerosis Center JSUMC, Neptune City
Lead Sponsor
Biogen
INDUSTRY